8625074

Source:http://linkedlifedata.com/resource/pubmed/id/8625074

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:8625074	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0006142	lld:lifeskim
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0030705	lld:lifeskim
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0442027	lld:lifeskim
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0015133	lld:lifeskim
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0282460	lld:lifeskim
pubmed-article:8625074	lifeskim:mentions	umls-concept:C0205179	lld:lifeskim
pubmed-article:8625074	pubmed:issue	12	lld:pubmed
pubmed-article:8625074	pubmed:dateCreated	1996-6-26	lld:pubmed
pubmed-article:8625074	pubmed:abstractText	The objective of this study was to define the activity and toxicity of etoposide for patients with previously treated metastatic breast cancer.	lld:pubmed
pubmed-article:8625074	pubmed:language	eng	lld:pubmed
pubmed-article:8625074	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8625074	pubmed:citationSubset	AIM	lld:pubmed
pubmed-article:8625074	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8625074	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:8625074	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:8625074	pubmed:month	Dec	lld:pubmed
pubmed-article:8625074	pubmed:issn	0008-543X	lld:pubmed
pubmed-article:8625074	pubmed:author	pubmed-author:VogelC LCL	lld:pubmed
pubmed-article:8625074	pubmed:author	pubmed-author:TrochMM	lld:pubmed
pubmed-article:8625074	pubmed:author	pubmed-author:SwainS MSM	lld:pubmed
pubmed-article:8625074	pubmed:author	pubmed-author:AtienzaD MDM	lld:pubmed
pubmed-article:8625074	pubmed:issnType	Print	lld:pubmed
pubmed-article:8625074	pubmed:day	15	lld:pubmed
pubmed-article:8625074	pubmed:volume	76	lld:pubmed
pubmed-article:8625074	pubmed:owner	NLM	lld:pubmed
pubmed-article:8625074	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:8625074	pubmed:pagination	2485-90	lld:pubmed
pubmed-article:8625074	pubmed:dateRevised	2010-3-24	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:meshHeading	pubmed-meshheading:8625074-...	lld:pubmed
pubmed-article:8625074	pubmed:year	1995	lld:pubmed
pubmed-article:8625074	pubmed:articleTitle	Phase II study of oral etoposide for patients with advanced breast cancer.	lld:pubmed
pubmed-article:8625074	pubmed:affiliation	Department of Medicine, VA Medical Center, Amarillo, Texas 79106, USA.	lld:pubmed
pubmed-article:8625074	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:8625074	pubmed:publicationType	Clinical Trial	lld:pubmed
pubmed-article:8625074	pubmed:publicationType	Review	lld:pubmed
pubmed-article:8625074	pubmed:publicationType	Research Support, Non-U.S. Gov't	lld:pubmed
pubmed-article:8625074	pubmed:publicationType	Clinical Trial, Phase II	lld:pubmed